Anti-Cancer activity of Novel Dibenzo[B,f]Azepine Tethered Isoxazoline derivatives

Sadashiva, M. P. and Basappa and Nanjunda Swamy, S. and Li, Feng and Manu, Kanjoormana Aryan and Sengottuvelan, Murugan and Prasanna, D. S. and Anilkumar, N. C. and Sethi, Gautam and Sugahara, Kazuyuki and Rangappa, K. S. (2012) Anti-Cancer activity of Novel Dibenzo[B,f]Azepine Tethered Isoxazoline derivatives. BMC Chemical Biology, 12. ISSN 1472-6769

Text (Full Text) Anti-Cancer Activity of Novel Dibenzo[B,f]Azepine Tethered Isoxazoline Derivatives.pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Background Dibenzoazepine (DB) derivatives are important and valuable compounds in medicinal chemistry. The synthesis and chemotherapeutic properties of naturally occurring DBs and different heterocyclic moiety tethered DBs are reported. Herein, we report the DB-fused hybrid structure that containing isoxazolines (DBIs) and their anti-cancer activity, which could throw light on the structural and functional features of new molecules. Results and Conclusion The synthesis and characterization of novel ring DB tethered isoxazoline derivatives (DBIs) were carried out. After the detailed structural characterization using 2D-NMR experiments, the compounds were identified as 5-substituted isoxazolines. The effect of newly synthesized DBIs against the invasion of murine osteosarcoma (LM8G7) cells was studied. Among the tested molecules, compound 4g (5-[−3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl-methyl]-5 H- dibenzo[b,f]azepine), was found to inhibit the invasion of LM8G7 cells strongly, when compared to other structurally related compounds. Cumulatively, the compound 4g inhibited the invasion MDA-MB-231 cells completely at 10 μM. In addition to anti-invasion property the compound 4g also inhibited the migration of LM8G7 and human ovarian cancer cells (OVSAHO) dose-dependently. Compound 4g inhibited the proliferation of LM8G7, OVSAHO, human breast cancer cells (MCF-7) and human melphalan-resistant multiple myeloma (RPMI8226-LR5) cells that are comparable to cisplatin and suramin.

Item Type:	Article
Subjects:	C Chemical Science > Chemistry
Divisions:	Department of > Chemistry
Depositing User:	C Swapna Library Assistant
Date Deposited:	17 Aug 2019 10:35
Last Modified:	17 Aug 2019 10:35
URI:	http://eprints.uni-mysore.ac.in/id/eprint/6690

Actions (login required)

View Item